Results
|
|
1.
|
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. MedStar authors:
Year: 2019
Citation: - Journal of Translational Medicine. 17(1):429, 2019 12 26.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Baste N, Clayburgh D, Cohen EEW, Fountzilas G, Fujii T, Khaliq A, Kim ES, Lin D, Lipworth L, Mehlhorn H, Melillo G, Pai SI, Resteghini C, Shara N, Shire N, Stokes M, Twumasi-Ankrah P, Wang H, Wildsmith S, Zhang J
|
|
|
2.
|
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade. MedStar authors:
Year: 2019
Citation: - Neurosurgery. 84(4):945-953, 2019 04 01.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Benzo S, Chen J, Chittiboina P, Dominah G, Gilbert MR, Giles AJ, Hayes CP, Heiss JD, Hourigan CS, Jackson S, Kuek A, Lynes J, Maric D, Nduom EK, Park DM, Quezado M, Sanchez V, Scott GC, Wang X, Wu J, Wu T, Zaghloul KA
|
|
|
3.
|
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors:
Year: 2017
Citation: - Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N
|
